Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01545947 |
Title | Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Celgene Corporation |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Cedars Sinai Medical Center, Inflammatory Bowel Disease Center | Los Angeles | California | 90048 | United States | Details | |
University of California, San Francisco | San Francisco | California | 9411 | United States | Details | |
NYU School of Medicine | New York | New York | 10016 | United States | Details | |
Cancer Center of the Carolinas | Greenville | South Carolina | 29605 | United States | Details | |
Henry-Joyce Cancer Clinic | Nashville | Tennessee | 37232-5505 | United States | Details | |
Mary Crowley Cancer Research Centers - Medical City | Dallas | Texas | 75201 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Vall d´Hebron University Hospital | Barcelona | 08035 | Spain | Details | ||
Hospital Virgen del Rocio Servicio de Hematologia | Sevilla | 41013 | Spain | Details |